Literature DB >> 9025777

Gastric mucosal blood flow and gastric secretion following intravenous administration of 5-fluorouracil in anesthetized rats.

S Kakinuma1, S Ohwada.   

Abstract

Acute gastric mucosal lesions are often observed after the intravenous administration of high doses of anticancer drugs. To investigate the acute toxic effects of such anticancer therapy on the gastric mucosa, 5-fluorouracil (5-FU) was administered intravenously to anesthetized rats. Gastric mucosal blood flow (GMBF) was measured continuously using laser Doppler velocimetry. Acid secretion was measured using a perfusion method for 1 h after the administration of 5-FU. No significant change was observed with a low dose of 5-FU (50 mg/kg), but a high doses of 5-FU (100 or 200 mg/kg) caused a significant decrease in GMBF in a dose-dependent manner. The selective antagonist of the muscarinic acetylcholine receptor, pirenzepine, prevented the decrease in GMBF with high doses of 5-FU. Acid secretion decreased after the administration of 5-FU, but not significantly. This study indicates that a decrease in GMBF may be an important factor in gastric mucosal injury induced by chemotherapy. Pirenzepine may prevent the gastric mucosal lesions which are induced by the administration of 5-FU.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9025777     DOI: 10.1007/s002800050583

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  3 in total

1.  Characterization of a novel mechanism accounting for the adverse cholinergic effects of the anticancer drug irinotecan.

Authors:  C Blandizzi; B De Paolis ; R Colucci; G Lazzeri; F Baschiera; M Del Tacca
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

2.  Impairment by 5-fluorouracil of the healing of gastric lesions in rats: effect of lafutidine, a histamine H2 receptor antagonist, mediated by capsaicin-sensitive afferent neurons.

Authors:  Yukiko Murashima; Tohru Kotani; Shusaku Hayashi; Yoshino Komatsu; Akari Nakagiri; Kikuko Amagase; Koji Takeuchi
Journal:  Dig Dis Sci       Date:  2008-07-02       Impact factor: 3.199

3.  Ileitis secondary to oral capecitabine treatment?

Authors:  Rami Radwan; Wanangwa C Namelo; Mark Robinson; Alison E Brewster; Gethin L Williams
Journal:  Case Rep Med       Date:  2012-11-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.